CoChat

Unsuccessful trial accrual and human subjects protections: An empirical analysis of recently closed trials

Open access

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Background: Ethical evaluation of risk–benefit in clinical trials is premised on the achievability of resolving research questions motivating an investigation. Objective: To determine the fraction and number of patients enrolled in trials that were at risk of not meaningfully addressing their primary research objective due to unsuccessful patient accrual. Methods: We used the National Library of Medicine clinical trial registry to capture all initiated phases 2 and 3 intervention clinical trials that were registered as closed in 2011. We then determined the number that had been terminated due to unsuccessful accrual and the number that had closed after less than 85% of the target number of human subjects had been enrolled. Five factors were tested for association with unsuccessful accrual. Results: Of 2579 eligible trials, 481 (19%) either terminated for failed accrual or completed with less than 85% expected enrolment, seriously compromising their statistical power. Factors associated with unsuccessful accrual included greater number of eligibility criteria (p = 0.013), non-industry funding (25% vs 16%, p < 0.0001), earlier trial phase (23% vs 16%, p < 0.0001), fewer number of research sites at trial completion (p < 0.0001) and at registration (p < 0.0001), and an active (non-placebo) comparator (23% vs 16%, p < 0.001). Conclusion: A total of 48,027 patients had enrolled in trials closed in 2011 who were unable to answer the primary research question meaningfully. Ethics bodies, investigators, and data monitoring committees should carefully scrutinize trial design, recruitment plans, and feasibility of achieving accrual targets when designing and reviewing trials, monitor accrual once initiated, and take corrective action when accrual is lagging.

Overview

Integrity signals

Registry

Crossref · 10.1177/1740774514558307

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 17 references

Cited by

See all 408

Metadata

Authors
Carlisle, B., Kimmelman, J., Ramsay, T., & MacKinnon, N.
Affiliations
  • McGill University (CA)
  • Ottawa Hospital Research Institute (CA)
Venue
Clinical Trials
Published
2014-12-04
Volume
12
Issue
1
Pages
77-83
ISSN
  • 1740-7745 (ISSN-L)
  • 1740-7753
OpenAlex
W2128251606
Cited by
367
References
16
Citations by year
2026: 29 · 2025: 35 · 2024: 44 · 2023: 37 · 2022: 55 · 2021: 53 · 2020: 37 · 2019: 24 · 2018: 23 · 2017: 18 · 2016: 8 · 2015: 3
FWCI
9.58
Type
journal article
Language
en
Open access
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Clinical Trials (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
Canadian Institutes of Health Research (MOP119574, 119574_1)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
  • Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
Keywords
clinical trial accrual, trial closure, research participant protection, risk-benefit assessment, statistical power, eligibility criteria, trial funding, trial phase, study sites, active comparator, trial design, data monitoring committees, ethical review
MeSH terms
Humans, Human Experimentation, Research Design, United States, Clinical Trials, Phase II as Topic, Clinical Trials, Phase III as Topic, Risk Assessment, Patient Selection, Early Termination of Clinical Trials

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Unsuccessful trial accrual and human subjects protections: An empirical analysis of recently closed trials. https://app.cochat.ai/papers/10.1177/1740774514558307
The paper
Carlisle, B., Kimmelman, J., Ramsay, T., & MacKinnon, N. (2015). Unsuccessful trial accrual and human subjects protections: An empirical analysis of recently closed trials. Clinical Trials. https://doi.org/10.1177/1740774514558307

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.